Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +51.68%
#2 TENDIES TENDIES +51.33%
#3 Pons Pons +46.87%
#4 PondCoin PondCoin +45.60%
#5 StonkBroker StonkBroker +34.96%
#6 Magma Finance Magma Finance +32.98%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.85%
#8 SkyAI SkyAI +28.36%
#9 Purr Purr +26.74%
#10 Ocean Protocol Ocean Protocol +26.36%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Resverlogix Corp. Resverlogix Corp.

Resverlogix Corp.

RVX
Rangering i aksjer #28673
Resverlogix Corporation is a biotechnology firm currently in advanced clinical... Resverlogix Corporation is a biotechnology firm currently in advanced clinical development, concentrating on developing treatments for illnesses where existing medical solutions are inadequate. The company's leading therapeutic compound is apabetalone (RVX-208), a selective small molecule designed to inhibit bromodomain and extra-terminal proteins. This compound is presently undergoing pivotal Phase III clinical trials for patients afflicted with conditions such as cardiovascular disease, diabetes, various stages of kidney disease (including end-stage renal disease), and neurodegenerative disorders. Furthermore, Resverlogix Corp. has forged an alliance with Eversana Life Science Services, LLC to support the forthcoming commercial rollout of apabetalone as a treatment for COVID-19 across the United States and Canada. The company's main office is located in Calgary, Canada.
Aksjekurs
$0.07339369
Sist synkronisert: 2026-08-18
Markedsverdi
$25.24M
Endring (1 dag)
5.26%
Endring (1 år)
-9.55%
Land
CA
Handel Resverlogix Corp. (RVX)

Kategori

Healthcare
Inntekter for Resverlogix Corp. (RVX)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Resverlogix Corp. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Resverlogix Corp. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH